Tecentriq

Medicinal product

(Invented) name

Tecentriq

Active substance (s)

Atezolizumabas

Strength

1875 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FF05, Atezolizumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2017-09-21

Date of renewal

Documents

Tecentriq paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	15 ml
Atezolizumabas	1875 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112540	98660	1098660	flakonas	15 ml N1		Receptinis	EU/1/17/1220/003	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-09-21	Registruotas